Bottom line
CHNA vs IYH: the short answer
CHNA (Loncar China BioPharma ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.
Updated Nov 19, 2026
CHNA vs IYH side by side
| CHNA | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Grayscale | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | — | 0.37% |
| Annual cost per $10k | — | $37 |
| 10-yr cost on $10k (prospectus) | — | $468 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +13.1% |
| 5-yr return (annualized) | — | +7.0% |
| 10-yr return (annualized) | — | +9.4% |
| Best quarter | — | +15.3% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | — | $3.6B |
| Number of holdings | — | 103 |
| Portfolio turnover | — | 3% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CHNA and IYH share none of their top holdings.
CHNA top 10
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between CHNA and IYH?
CHNA (Loncar China BioPharma ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.
Should I own both CHNA and IYH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.